TARA SPALDING: Open Payments
NPI 1255812129 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,613 in 75 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,613
Food & beverage: $1,613
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $374 |
| Janssen Biotech, Inc. | 16 | $330 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $311 |
| Ardelyx, Inc. | 7 | $168 |
| Regeneron Healthcare Solutions, Inc. | 3 | $85 |
| Lilly USA, LLC | 4 | $80 |
| Phathom Pharmaceuticals, Inc. | 5 | $80 |
| Ipsen Biopharmaceuticals, Inc | 3 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $48 |
| Madrigal Pharmaceuticals | 1 | $25 |
Products named: TREMFYA, RINVOQ, ENTYVIO, IBSRELA, DUPIXENT, SKYRIZI, OMVOH, VOQUEZNA.
Industry payments across VA — which companies pay providers there.
